{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:48:39Z","timestamp":1791863319818,"version":"4.3.4"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1097\/nrl.0b013e318247bc91","type":"journal-article","created":{"date-parts":[[2012,2,24]],"date-time":"2012-02-24T09:39:51Z","timestamp":1330076391000},"page":"76-79","source":"Crossref","is-referenced-by-count":18,"title":["Anti-aquaporin-4 Antibody-positive Definite Neuromyelitis Optica in a Patient With Thymectomy for Myasthenia Gravis"],"prefix":"10.1097","volume":"18","author":[{"given":"Kotaro","family":"Ogaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Chijiiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Fukae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Furuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Noda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Fujishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Okuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210211","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devics syndrome).","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"key":"R2-6-20210211","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"R3-6-20210211","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/brain\/awm062","article-title":"Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titer.","volume":"130","author":"Takahashi","year":"2007","journal-title":"Brain"},{"key":"R4-6-20210211","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica.","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"R5-6-20210211","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica.","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"key":"R6-6-20210211","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity.","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol"},{"key":"R7-6-20210211","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1212\/01.WNL.0000115168.73299.88","article-title":"Devic disease and thymoma with anti-central nervous system and antithymus antibodies.","volume":"62","author":"Antoine","year":"2004","journal-title":"Neurology"},{"key":"R8-6-20210211","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1468-1331.2006.01392.x","article-title":"Neuromyelitis optica associated with myasthenia gravis: characteristic phenotype in Japanese population.","volume":"13","author":"Furukawa","year":"2006","journal-title":"Eur J Neurol"},{"key":"R9-6-20210211","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/archneur.63.6.851","article-title":"Neuromyelitis optica in patients with myasthenia gravis who underwent thymectomy.","volume":"63","author":"Kister","year":"2006","journal-title":"Arch Neurol"},{"key":"R10-6-20210211","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1212\/01.wnl.0000234142.41728.a0","article-title":"Occurrence of CNS demyelinating disease in patients with myasthenia gravis.","volume":"67","author":"Gotkine","year":"2006","journal-title":"Neurology"},{"key":"R11-6-20210211","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1177\/13524585070130030201","article-title":"Clinical and laboratory features of neuromyelitis optica with oligoclonal IgG bands.","volume":"13","author":"Nakamura","year":"2007","journal-title":"Mult Scler"},{"key":"R12-6-20210211","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1212\/01.wnl.0000262954.51568.25","article-title":"Occurrence of CNS demyelinating disease in patients with myasthenia gravis.","volume":"68","author":"Ikeda","year":"2007","journal-title":"Neurology"},{"key":"R13-6-20210211","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1590\/S0004-282X2008000100002","article-title":"Demyelinating disease in patients with myasthenia gravis.","volume":"66","author":"Bichuetti","year":"2008","journal-title":"Arq Neuropsiquiatr"},{"key":"R14-6-20210211","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jns.2008.06.038","article-title":"NMO-IgG positive neuromyelitis optica in a patient with myasthenia gravis but no thymectomy.","volume":"275","author":"Kay","year":"2008","journal-title":"J Neurol Sci"},{"key":"R15-6-20210211","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jns.2009.08.040","article-title":"Association of anti-aquaporin-4 antibody-positive neuromyelitis optica with myasthenia gravis.","volume":"287","author":"Uzawa","year":"2009","journal-title":"J Neurol Sci"},{"key":"R16-6-20210211","first-page":"859","article-title":"Epidemiology of multiple sclerosis in Japanese: with special reference to opticospinal multiple sclerosis.","volume":"46","author":"Kira","year":"2006","journal-title":"Rinsho Shinkeigaku"},{"key":"R17-6-20210211","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/1352458508098372","article-title":"Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years.","volume":"15","author":"Osoegawa","year":"2009","journal-title":"Mult Scler"},{"key":"R18-6-20210211","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1177\/1352458508090226","article-title":"Increasing prevalence and incidence of multiple sclerosis in northern Japan.","volume":"14","author":"Houzen","year":"2008","journal-title":"Mult Scler"},{"issue":"suppl 3","key":"R19-6-20210211","first-page":"A467","article-title":"Nationwide epidemiological survey of myasthenia gravis in Japan.","volume":"72","author":"Murai","year":"2009","journal-title":"Neurology"},{"key":"R20-6-20210211","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/mus.21197","article-title":"Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica.","volume":"39","author":"Mckeon","year":"2009","journal-title":"Muscle Nerve"},{"key":"R21-6-20210211","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0091-6749(99)70431-8","article-title":"Long-term immunologic effects of thymectomy in patients with myasthenia gravis.","volume":"103","author":"Gerli","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"R22-6-20210211","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1212\/WNL.24.1.72","article-title":"Myasthenia gravis and multiple sclerosis: an unusual combination of diseases.","volume":"24","author":"Aita","year":"1974","journal-title":"Neurology"},{"key":"R23-6-20210211","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0022-510X(89)90005-1","article-title":"Myasthenia gravis associated with multiple sclerosis. Epidemiological survey and immunological findings.","volume":"89","author":"Somer","year":"1989","journal-title":"J Neurol Sci"},{"key":"R24-6-20210211","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1191\/1352458503ms964oa","article-title":"Co-occurrence of multiple sclerosis and myasthenia gravis in British Columbia.","volume":"9","author":"Isbister","year":"2003","journal-title":"Mult Scler"},{"key":"R25-6-20210211","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000329576","article-title":"Association of Th1Th2-related chemokine receptors in peripheral T cells with disease activity in patients with multiple sclerosis and neuromyelitis optica.","volume":"66","author":"Shimizu","year":"2011","journal-title":"Eur Neurol"},{"key":"R26-6-20210211","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1471-2377-10-113","article-title":"Expression of chemokine receptors on peripheral blood lymphocytes in multiple sclerosis and neuromyelitis optica.","volume":"10","author":"Uzawa","year":"2010","journal-title":"BMC Neurol"},{"issue":"suppl 3","key":"R27-6-20210211","first-page":"A232","article-title":"Thymectomy alters chemokine receptor expression on T cells in myasthenia gravis: correction of Th1Th2 imbalance after thymectomy.","volume":"56","author":"Suzuki","year":"2001","journal-title":"Neurology"},{"key":"R28-6-20210211","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ejphar.2009.10.040","article-title":"Clinical implication of the type 1type 2 balance of helper T cells and P-glycoprotein function in peripheral T lymphocytes of myasthenia gravis patients.","volume":"627","author":"Masuda","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"R29-6-20210211","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0b013e3181c919ee","article-title":"B-cell activating factor of the TNF family is upregulated in neuromyelitis optica.","volume":"74","author":"Okada","year":"2010","journal-title":"Neurology"},{"key":"R30-6-20210211","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.athoracsur.2010.08.041","article-title":"Comparative clinical features and immune responses after extended thymectomy for myasthenia gravis in patients with atrophic versus hyperplastic thymus.","volume":"91","author":"Chen","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"R31-6-20210211","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/archneur.65.10.1358","article-title":"A potential role for B-cell activating factor in the pathogenesis of autoimmune myasthenia gravis.","volume":"65","author":"Ragheb","year":"2008","journal-title":"Arch Neurol"}],"container-title":["The Neurologist"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00127893-201203000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:25:53Z","timestamp":1618035953000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00127893-201203000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/nrl.0b013e318247bc91","relation":{},"ISSN":["1074-7931"],"issn-type":[{"value":"1074-7931","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}